CA2237998A1 - Chemokine issue du pancreas d'un sujet a diabete non insulinodependant sucre - Google Patents
Chemokine issue du pancreas d'un sujet a diabete non insulinodependant sucre Download PDFInfo
- Publication number
- CA2237998A1 CA2237998A1 CA002237998A CA2237998A CA2237998A1 CA 2237998 A1 CA2237998 A1 CA 2237998A1 CA 002237998 A CA002237998 A CA 002237998A CA 2237998 A CA2237998 A CA 2237998A CA 2237998 A1 CA2237998 A1 CA 2237998A1
- Authority
- CA
- Canada
- Prior art keywords
- mcp
- expression
- sequence
- subject
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Abstract
L'invention concerne un polynucléotide (mcp-4) qui assure l'identification et le codage d'une nouvelle protéine 4 ayant une activité chimiotactique sur les monocytes (MCP-4), exprimée dans les cellules du pancréas d'un sujet à diabète non insulinodépendant sucré. On décrit par ailleurs des molécule antisens, des vecteurs d'expression obtenus par génie génétique ainsi que des cellules hôtes pour la production de MCP-4 purifiées. On décrit aussi des anticorps, des antagonistes et des inhibiteurs assurant spécifiquement la liaison de MCP-4 ainsi que des compositions pharmaceutiques et des procédés de traitement reposant sur le polypeptide considéré, y compris les antagonistes et les inhibiteurs de ce polypeptide. On décrit spécifiquement l'utilisation du polypeptide pour le contrôle positif lié à des tests de diagnostic qui permettent aussi d'identifier l'expression mcp-4 modifiée. Les tests en question font appel à des compositions diagnostiques élaborées à partir de séquences polynucléotidiques à codage mcp-4 ou complémentaires, y compris des oligomères, et à partir d'anticorps anti-MCP-4.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US680995P | 1995-11-15 | 1995-11-15 | |
US60/006,809 | 1995-11-15 | ||
US56633495A | 1995-12-01 | 1995-12-01 | |
US08/566,334 | 1995-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2237998A1 true CA2237998A1 (fr) | 1997-05-22 |
Family
ID=26676094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002237998A Abandoned CA2237998A1 (fr) | 1995-11-15 | 1996-11-15 | Chemokine issue du pancreas d'un sujet a diabete non insulinodependant sucre |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0869972A1 (fr) |
JP (1) | JP2000500970A (fr) |
AU (1) | AU7735696A (fr) |
CA (1) | CA2237998A1 (fr) |
WO (1) | WO1997018237A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU733925C (en) * | 1996-03-27 | 2002-06-13 | Icos Corporation | Monocyte chemotactic protein-5 materials and methods |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0679716A4 (fr) * | 1993-11-12 | 1999-06-09 | Kenichi Matsubara | Signature genique. |
KR970703353A (ko) * | 1994-05-16 | 1997-07-03 | 로버트 에이치. 벤슨 | 단핵구 주화성 단백질-4(monocyte chemotactic protein-4) |
JPH10508742A (ja) * | 1994-08-23 | 1998-09-02 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | ヒトケモカインポリペプチド |
-
1996
- 1996-11-15 JP JP9519123A patent/JP2000500970A/ja active Pending
- 1996-11-15 CA CA002237998A patent/CA2237998A1/fr not_active Abandoned
- 1996-11-15 WO PCT/US1996/018398 patent/WO1997018237A1/fr not_active Application Discontinuation
- 1996-11-15 EP EP96940487A patent/EP0869972A1/fr not_active Withdrawn
- 1996-11-15 AU AU77356/96A patent/AU7735696A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2000500970A (ja) | 2000-02-02 |
EP0869972A1 (fr) | 1998-10-14 |
WO1997018237A1 (fr) | 1997-05-22 |
AU7735696A (en) | 1997-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020058241A1 (en) | Novel human stem cell antigens | |
CA2257130A1 (fr) | Homologue inhibiteur de proteine kinase-amp cyclique dependante humaine | |
US5834192A (en) | Human cachexia associated protein | |
WO1998006841A2 (fr) | Deux proteines humaines du genre nsp | |
US5780235A (en) | Human voltage-dependent anion channel | |
US5712115A (en) | Human cell death-associated protein | |
CA2253541A1 (fr) | Inhibiteur de la phospholipase chez l'homme | |
US6238666B1 (en) | RANTES homolog antibody | |
CA2231427A1 (fr) | Nouvelle enzyme humaine conjuguant l'ubiquitine | |
CA2257528A1 (fr) | Homologue inhibiteur de proteine kinase c humaine | |
CA2261573A1 (fr) | Nouvelle proteine associee a un gene recepteur de la leptine humaine | |
US5916556A (en) | Human MRNA editing enzyme | |
US20020034777A1 (en) | Novel regulator of cell signaling | |
CA2237998A1 (fr) | Chemokine issue du pancreas d'un sujet a diabete non insulinodependant sucre | |
US20020034510A1 (en) | Novel atpase inhibitor | |
CA2263165A1 (fr) | Proteine de la tumeur induite chez l'homme | |
EP0932687A1 (fr) | Nouvelle sous-unite gamma de la phosphorylase kinase humaine | |
CA2263818A1 (fr) | Nouvelles proteines de tumeurs | |
EP0958365A1 (fr) | Variante de la proteine-2 chimiotactique de granulocytes | |
US20020164704A1 (en) | Novel human monocyte chemotactic proprotein | |
CA2270173A1 (fr) | Inhibiteur de kazal associe aux tumeurs et homologue de pec-60 | |
US20020155538A1 (en) | Novel endothelial growth factor | |
MXPA98003883A (en) | Chemiocine from pancreas de melitus de diabetes that does not depend on insul |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |